TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sonic Healthcare Limited ( (AU:SHL) ) has shared an update.
Sonic Healthcare Limited announced a change in the director’s interest, with James Pacey Newcombe acquiring 345,342 unlisted options and 50,481 unlisted performance rights over ordinary shares. These securities will vest in 2028, contingent on performance criteria, as part of the company’s long-term incentive plan approved at the 2025 AGM. This move reflects the company’s strategy to align executive compensation with performance, potentially impacting its operational focus and stakeholder interests by incentivizing leadership to meet long-term goals.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing medical diagnostic services. The company is known for its comprehensive range of laboratory and radiology services, catering to a wide market that includes hospitals, medical practitioners, and patients globally.
Average Trading Volume: 1,683,183
Technical Sentiment Signal: Sell
Current Market Cap: A$11.41B
For detailed information about SHL stock, go to TipRanks’ Stock Analysis page.